Please login to the form below

Not currently logged in
Email:
Password:

vaccines

This page shows the latest vaccines news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s Prevnar-13 successor takes aim at Merck rival

Pfizer’s Prevnar-13 successor takes aim at Merck rival

Pfizer’ s Prevnar-13 successor takes aim at Merck rival. Pfizer just got a leg-up in its race with Merck &Co/MSD to bring a new-generation pneumococcal vaccine to ... continue to build on our expertise in pneumococcal conjugate vaccines with this

Latest news

More from news
Approximately 108 fully matching, plus 1,036 partially matching documents found.

Latest Intelligence

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    cell-based therapies and oncolytic viruses that attack malignant cells directly, and cancer vaccines that try to kickstart an intrinsic immune reaction to the tumour. ... Vaccines. While the first therapeutic cancer vaccines have reached the market, eg

  • Advancing women in healthcare Advancing women in healthcare

    She joined Merck &Co in 2009 and sees her role in promoting vaccines and facilitating greater access to them in all parts of the world as an extension of this same ... Dr Priya Agrawal is Business Unit Director, Vaccines &Women’s Health at MSD.

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    Newer plans to lower the QALY for vaccines to £15, 000 should alarm all companies, as it suggests that the QALY for all medicines could also be lowered. ... This is essential. Vaccines are an interesting case study for the post-Brexit world.

  • Health on instalment Health on instalment

    The only apt parallel might be the discovery of antibiotics or vaccines, but even those milestones may end up paling in comparison.

  • Deal Watch January 2018

    Royalty monetisation, share purchase. 250. Agenus/HealthCare Royalty Partners. Royalties on sales of GSK's QS-21 containing vaccines. ... In October 2017 GSK's QS-21 Stimulon herpes zoster vaccine, Shingrix, was approved by the FDA.

More from intelligence
Approximately 5 fully matching, plus 75 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 61 partially matching documents found.

Latest from PMHub

  • Money, sex and power

    Social history will record that whilst vaccines, nylon, biotech, the jet engine, the silicon chip, networks, social media and nuclear energy all seemed like big ideas we’ ve only just made

  • PRMA Consulting Ltd

    Our experience encompasses a wide range of indications, including; cardiovascular and renal, gastroenterology, immunology, infectious diseases and vaccines, metabolism and endocrinology, neurology and psychiatry, oncology/hematology, ophthalmology,

  • Infographic: The vaccine opportunity in Asia

    Infographic: The vaccine opportunity in Asia. As predicted, the vaccine market in emerging and developing countries has continued to expand. ... Download our latest infographic in which we explore the vaccine opportunity in Asia.

  • Case Study: Private market opportunity for a travel vaccine

    Case Study: Private market opportunity for a travel vaccine. Our client needed exploratory research to determine the global opportunity for a new travel vaccine in the private market. ... travel. Who the key stakeholders were in each market, in terms of

  • Exploring the Opportunity For Halal In Healthcare

    As pork is forbidden by Islam, the use of pork-based gelatin in many vaccines has resulted in considerable resistance to vaccination among the Islamic community. ... Data has demonstrated a decrease in immunization rates in majority Muslim countries such

More from PMHub
Approximately 5 fully matching, plus 27 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics